{
    "title": "Melb firm trials muscular dystrophy drug",
    "url": "https://www.dailymail.co.uk/wires/aap/article-7855421/Melb-firm-trials-muscular-dystrophy-drug.html",
    "date": "2020-01-06",
    "keywords": [
        "treatment",
        "company",
        "antisense",
        "trial",
        "drug",
        "dystrophy",
        "diamond",
        "atl1102",
        "royal",
        "europe",
        "dose",
        "director",
        "year",
        "disease",
        "therapy",
        "biotech",
        "disorder",
        "study",
        "candidate",
        "wheelchair",
        "form",
        "muscle",
        "weakness",
        "wasting",
        "death",
        "cure",
        "executive",
        "mark",
        "option",
        "approval",
        "monday",
        "december",
        "grip",
        "strength",
        "change",
        "stabilisation",
        "improvement",
        "dmd",
        "boys",
        "result",
        "dr",
        "thomas",
        "research",
        "centre",
        "london",
        "phase",
        "half",
        "course",
        "number",
        "mr",
        "injection",
        "cell",
        "receptor",
        "bodys",
        "immune",
        "system",
        "inflammation",
        "part",
        "strategy",
        "rna",
        "faulty",
        "ionis",
        "leader",
        "sarepta",
        "cent",
        "gene",
        "mutation",
        "value",
        "potential",
        "chairman",
        "william",
        "goolsbee"
    ],
    "category": [
        "wires",
        "aap"
    ]
}